Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$595.73 USD

595.73
704,928

+5.74 (0.97%)

Updated Jul 25, 2024 04:00 PM ET

After-Market: $595.76 +0.03 (0.01%) 7:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 42% (105 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

If You Invested $1000 in McKesson a Decade Ago, This is How Much It'd Be Worth Now

by Zacks Equity Research

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

McKesson (MCK) Gains As Market Dips: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed the most recent trading day at $330.44, moving +0.8% from the previous trading session.

Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXG

McKesson (MCK) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, McKesson (MCK) closed at $327.81, marking a +0.37% move from the previous day.

Here's Why You Should Hold on to OPKO Health (OPK) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and a few strategic agreements.

Potbelly's and Rio Tinto have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Potbelly's and Rio Tinto have been highlighted as Zacks Bull and Bear of the Day.

Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?

by Zacks Equity Research

Sector ETF report for FXG

QIAGEN (QGEN) QCI's Robust Adoption to Enhance Patient Outcome

by Zacks Equity Research

QIAGEN's (QGEN) QCI platform is expected to significantly streamline NGS data analysis and variant interpretation, and enable swift and confident shift by users from raw NGS data to clinical report.

Indrajit Bandyopadhyay headshot

3 Medical Device Stocks With Potential to Fight Recession Risk

by Indrajit Bandyopadhyay

The decline in U.S. GDP during the first quarter and 26% decline in the S&P 500 Index so far this year fuel the risk of a recession. MCK, PDCO & AMN have the potential to help investors ward off volatility risks going forward.

NextGen (NXGN)-InstaMed Ink Deal to Improve Payment Processing

by Zacks Equity Research

NextGen's (NXGN) latest expanded deal with InstaMed is expected to significantly simplify payment methods for both patients and providers.

3 Reasons to Retain DaVita (DVA) Stock in Your Portfolio

by Zacks Equity Research

Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care.

Reasons to Retain Surmodics (SRDX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.

Alcon's (ALC) Product Launches, Market Recovery Aid Growth

by Zacks Equity Research

Despite bearing the brunt of inflationary pressure across both Total Surgical and Vision Care franchises, Alcon (ALC) succeeds in mitigating much of the impact through cost-improvement efforts.

McKesson (MCK) Gains But Lags Market: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed at $330 in the latest trading session, marking a +1.08% move from the prior day.

3 Reasons Why BD (BDX) is a Great Pick For Your Portfolio Now

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.

Has McKesson (MCK) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how McKesson (MCK) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.

Zacks Value Trader Highlights: H&R Block, McKesson, Stride, TransAlta and Murphy USA

by Zacks Equity Research

H&R Block, McKesson, Stride, TransAlta and Murphy USA are part of Zacks Value Trader blog.

Tracey Ryniec headshot

5 Value Stocks Near Their 52-Week Highs

by Tracey Ryniec

Not every stock is selling off in 2022. Here are 5 cheap stocks with high Zacks Rank trading near their 52-week highs.

Derek Lewis headshot

This Medical Supplier Is Pushing All-Time Highs

by Derek Lewis

McKesson shares have been scorching-hot year-to-date, increasing by more than 30% in value and extensively outperforming both its Zacks Sector and the S&P 500.

McKesson (MCK) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, McKesson (MCK) closed at $325.18, marking a -0.67% move from the previous day.

McKesson (MCK) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does McKesson (MCK) have what it takes to be a top stock pick for momentum investors? Let's find out.

Is McKesson (MCK) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today

by Zacks Equity Research

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

McKesson (MCK) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed the most recent trading day at $321.25, moving -0.09% from the previous trading session.

Here's Why You Should Retain McKesson (MCK) Stock Right Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.